首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   8619篇
  免费   518篇
  国内免费   138篇
耳鼻咽喉   126篇
儿科学   169篇
妇产科学   82篇
基础医学   1420篇
口腔科学   142篇
临床医学   712篇
内科学   1821篇
皮肤病学   478篇
神经病学   626篇
特种医学   577篇
外科学   1038篇
综合类   33篇
现状与发展   1篇
一般理论   1篇
预防医学   319篇
眼科学   192篇
药学   860篇
中国医学   144篇
肿瘤学   534篇
  2024年   5篇
  2023年   55篇
  2022年   237篇
  2021年   341篇
  2020年   181篇
  2019年   232篇
  2018年   289篇
  2017年   232篇
  2016年   323篇
  2015年   406篇
  2014年   512篇
  2013年   488篇
  2012年   789篇
  2011年   777篇
  2010年   409篇
  2009年   380篇
  2008年   504篇
  2007年   443篇
  2006年   359篇
  2005年   391篇
  2004年   267篇
  2003年   225篇
  2002年   232篇
  2001年   178篇
  2000年   188篇
  1999年   138篇
  1998年   65篇
  1997年   40篇
  1996年   46篇
  1995年   23篇
  1994年   45篇
  1993年   26篇
  1992年   44篇
  1991年   45篇
  1990年   42篇
  1989年   59篇
  1988年   37篇
  1987年   38篇
  1986年   26篇
  1985年   24篇
  1984年   14篇
  1983年   8篇
  1982年   15篇
  1981年   12篇
  1980年   17篇
  1979年   16篇
  1978年   7篇
  1977年   9篇
  1976年   6篇
  1967年   4篇
排序方式: 共有9275条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
6.
7.

Background and aims

It is not known whether non alcoholic fatty liver disease (NAFLD) is a risk factor for diabetes in non obese, non centrally-obese subjects. Our aim was to investigate relationships between fatty liver, insulin resistance and a biomarker score for liver fibrosis with incident diabetes at follow up, in subjects who were neither obese nor centrally-obese.

Methods and results

As many as 70,303 subjects with a body mass index (BMI) < 25 kg/m2 and without diabetes were followed up for a maximum of 7.9 years. At baseline, fatty liver was identified by liver ultrasound, insulin resistance (IR) by homeostatic model assessment of insulin resistance (HOMA-IR) ≥2.0, and central obesity by waist circumference (waist circumference ≥90 cm (men) and ≥85 cm (women). The Fibrosis-4 (FIB-4 score) was used to estimate extent of liver fibrosis. Cox proportional hazards models adjusted for confounders were used to estimate hazard ratios (aHRs) for incident diabetes. As many as 852 incident cases of diabetes occurred during follow up (median [IQR] 3.71 [2.03] years). Mean ± SD BMI was 22.8 ± 1.8 and 21.7 ± 2.0 kg/m2 in subjects with and without diabetes at follow up. In subjects without central obesity and with fatty liver, aHRs (95% CI) for incident diabetes at follow up were 2.17 (1.56, 3.03) for men, and 2.86 (1.50,5.46) for women. Similar aHRs for incident diabetes occurred with fatty liver, IR and the highest quartile of FIB-4 combined, in men; and there was a non significant trend toward increased risk in women.

Conclusions

In normal weight, non-centrally obese subjects NAFLD is an independent risk factor for incident diabetes.  相似文献   
8.
ABSTRACT

Genotoxic compounds may be detoxified to non-genotoxic metabolites while many pro-carcinogens require metabolic activation to exert their genotoxicity in vivo. Standard genotoxicity assays were developed and utilized for risk assessment for over 40 years. Most of these assays are conducted in metabolically incompetent rodent or human cell lines. Deficient in normal metabolism and relying on exogenous metabolic activation systems, the current in vitro genotoxicity assays often have yielded high false positive rates, which trigger unnecessary and costly in vivo studies. Metabolically active cells such as hepatocytes have been recognized as a promising cell model in predicting genotoxicity of carcinogens in vivo. In recent years, significant advances in tissue culture and biological technologies provided new opportunities for using hepatocytes in genetic toxicology. This review encompasses published studies (both in vitro and in vivo) using hepatocytes for genotoxicity assessment. Findings from both standard and newly developed genotoxicity assays are summarized. Various liver cell models used for genotoxicity assessment are described, including the potential application of advanced liver cell models such as 3D spheroids, organoids, and engineered hepatocytes. An integrated strategy, that includes the use of human-based cells with enhanced biological relevance and throughput, and applying the quantitative analysis of data, may provide an approach for future genotoxicity risk assessment.  相似文献   
9.
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号